These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27365069)

  • 1. [Coronary Artery Bypass Grafting for In-stent Restenosis Probably Caused by Allergic Response;Report of a Case].
    Eda T; Teshima Y; Suga K; Hayashi K; Miyake Y; Umeda H; Ishiki R
    Kyobu Geka; 2016 Jul; 69(7):545-7. PubMed ID: 27365069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal allergy to everolimus-eluting cobalt chromium stents confirmed by positive skin testing as a cause of recurrent multivessel in-stent restenosis.
    Nakajima Y; Itoh T; Morino Y
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):E137-42. PubMed ID: 26011018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-pump coronary endarterectomy with stent removal for in-stent restenosis in the left anterior descending artery.
    Nishigawa K; Fukui T; Takanashi S
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):594-7. PubMed ID: 26273070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug-eluting stents restenosis 2 months after the procedure and necessitating semi-emergency off-pump coronary artery bypass].
    Iwakura T; nomoto S; Yamamoto K; Fujita T; Ohira N; Sakamoto T; Okamura H
    Kyobu Geka; 2006 May; 59(5):369-72. PubMed ID: 16715886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioresorbable vascular scaffold to treat malignant in-stent restenosis in a patient with nickel allergy.
    Jurado-Román A; López-Lluva MT; Sánchez-Pérez I; Piqueras-Flores J; Maseda R; Lozano-Ruíz-Poveda F
    Cardiovasc Revasc Med; 2017 Sep; 18(6S1):38-40. PubMed ID: 28089777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Subacute thrombosis of drug eluting stent immediately after off-pump coronary artery bypass grafting].
    Shiiku C; Kikuchi Y; Mitsube K
    Kyobu Geka; 2010 Jul; 63(7):561-4. PubMed ID: 20662236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of left anterior descending coronary artery stenosis: stent or surgery.
    Sismanoglu M; Sarikaya S; Onk OA; Adademir T; Aksoy E; Kirali K
    Asian Cardiovasc Thorac Ann; 2013 Oct; 21(5):528-32. PubMed ID: 24570553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of everolimus-eluting stent with a bioresorbable polymer coating for treatment of recurrent in-stent restenosis.
    Honda H; Meguro T; Takizawa K; Isoyama S
    J Invasive Cardiol; 2005 Feb; 17(2):112-5. PubMed ID: 15687539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
    Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of everolimus-eluting stents for bare-metal in-stent restenosis.
    Ota H; Mahmoudi M; Torguson R; Satler LF; Suddath WO; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2015; 16(3):151-5. PubMed ID: 25977226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
    Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA;
    JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery aneurysm occurring very late after drug-eluting stent implantation.
    Okamura K; Suematsu Y; Morizumi S; Kawata M
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1068-70. PubMed ID: 25164132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aortitis syndrome with repeated restenoses of a drug eluting stent].
    Katayama Y; Sato H; Kitajima S; Yoshitake S; Noguichi R; Furukawa K; Okazaki Y; Morita S
    Kyobu Geka; 2009 May; 62(5):364-8. PubMed ID: 19425374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
    Qasim A; Cosgrave J; Latib A; Colombo A
    Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous unprotected left main angioplasty with drug-eluting stents in a nonagenarian: feasible and safe despite recurrent restenosis.
    Sillano D; Moretti C; Biondi-Zoccai G; Sheiban I
    Minerva Cardioangiol; 2008 Feb; 56(1):167-70. PubMed ID: 18432178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid coronary revascularization in the era of drug-eluting stents.
    Murphy GJ; Bryan AJ; Angelini GD
    Ann Thorac Surg; 2004 Nov; 78(5):1861-7. PubMed ID: 15511503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.
    Dangas G; Ellis SG; Shlofmitz R; Katz S; Fish D; Martin S; Mehran R; Russell ME; Stone GW;
    J Am Coll Cardiol; 2005 Apr; 45(8):1186-92. PubMed ID: 15837247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis.
    Ota H; Mahmoudi M; Kitabata H; Torguson R; Chen F; Satler LF; Suddath WO; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2015 Mar; 16(2):84-9. PubMed ID: 25870152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.